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Introduction
Type 1 diabetes (T1D) is a genetically complex disorder of glucose 
homeostasis caused by autoimmune mediated self-destruction of 
insulin-secreting cells of the pancreas. The disease is thought to be the 
result of exposure to environmental factors combined with genetic 
susceptibility that contribute to the development of T1D in a complex 
manner [1]. To date, genetic predisposition to T1D has been associated 
to more than 20 confirmed genetic loci [2].
The strongest risk for T1D is conferred by the major 
histocompatibility complex, class II, DQ beta 1 gene (HLA-DQB1) also 
named as Insulin Dependent Diabetes Mellitus gene (IDDM1). It has 
been estimated that about 40% of heritable risk can be explained by 
IDDM susceptibility genes [3]. The Cytotoxic-T-lymphocyte antigen 
(CTLA-4, CD-152) encoding gene (IDDM12) is one of the most 
important non-HLA susceptibility genes of T1D and other autoimmune 
diseases. IDDM12 maps to chromosome 2q33 [4]. The role of CTLA-4 
in the autoimmune process has been emphasized by its association with 
systemic lupus erythematosus, celiac disease, rheumatoid arthritis, and 
autoimmune thyroid diseases [5]. CTLA-4 is a receptor, that down-
regulates the immune response. The IDDM12 gene contains a cluster of 
T lymphocyte-regulating genes including CTLA-4, CD28, and inducible 
T-cell co-stimulator (ICOS). CD28 and CTLA-4 are co-stimulatory 
receptors that together with the antigen specific T-cell receptor (TCR) 
bind the B7 family molecules on the surface of antigen presenting cells 
(APC). CD28 enhances whereas CTLA-4 inhibits T-cell proliferation. 
Binding of CTLA-4 to the B7 limits the proliferation of T-cells and 
terminates the ongoing immune response [6]. CTLA-4 knockout mice 
develop severe lymphoproliferative disorder; die within a few days 
after birth, highlighting the importance of this gene in the negative 
regulation of the immune response [7]. Recently, the susceptibility for 
T1D was remapped to the 3’untranslated region (UTR) of the CTLA-
4 gene [8]. The previously implicated +49 and CT60 variants were 
confirmed to have the strongest association withT1D but the mapping 
of the causal variant remained ambiguous and did not exclude the 
possibility of association with multiple functional variants. Apart from 
re-sequencing, association of CTLA-4 variants in different populations 
is a strategy for further fine mapping. In general, the compelling data 
on the association of CTLA-4 polymorphisms with T1D is convincing 
in some populations including Belgian [4,9], French, Italian, Korean, 
Mexican, Spanish–American [10], Japanese [11-15], Chinese [16], 
Russian [17], British [18], Moroccan [19], Estonian [20], and Croatian 
[21] populations.
On the other hand, further studies found no association in Chinese 
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Abstract
Background: Polymorphisms in the cytotoxic T-lymphocyte antigen 4 (CTLA-4) are associated with the risk of 
type 1 diabetes (T1D). Here, we investigated the most associated variants CT60 and +49 A/G and five other putative 
promoter SNPs for their association with T1D in the Egyptian population, a multi-ethnic group. The comparison of 
disease association between populations can provide further evidence for putative disease variants.
Methods: Association of seven SNPs (-1722,-1661,-651,-319, +49, -819 and +6230G>A) in the CTLA-4 gene 
with T1D was investigated in 396 patient and 396 control subjects of Egyptian origin. The diagnosis of T1D was 
made based on ketoacidosis or ketosis with acute onset and severe symptoms of diabetes mellitus at presentation 
and continuous dependence on insulin. Controls were negative for anti-GAD antibodies and were older than 24 
years of age. Genotyping was performed using polymerase chain reaction-restriction fragment length polymorphism 
(PCR-RFLP). 
Results: Five of the seven CTLA-4 gene SNPs were associated with T1D with the highest association for 
+49 A/G in exon 1 (P=0.0002; odds ratio: 1.6, 95% CI 1.3-1.9). Association conditional on SNP +49 A/G was 
further tested, revealing some independent association for SNPs -1661 and -318. Haplotype analysis of these SNPs 
demonstrated that no single haplotype was indicative of T1D risk. 
Conclusion: The results further support the association of T1D with+49 A/G SNP in the CTLA-4 gene in the 
Egyptian population. The pattern of association specifically differed from that observed in European and other North 
African populations, providing further opportunity for fine mapping of genetic disease variants of type-I diabetes.
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[10], Japanese [22-24], Czech [25], Iranian [26], Argentinean [27], 
Chilean [28], Portuguese [29] and Turkish [30] children.
These distinct association patterns in different populations may 
provide important clues to clarify the causal variants by exploiting 
recombination events in the past that may generate distinct CTLA-
4 haplotypes, whose frequencies may vary between races [31]. In 
this study, we investigated whether the seven most implicated Single 
Nucleotide Polymorphism (SNPs) of the CTLA-4 gene are associated 
with T1D in the Egyptian population.
Materials and Methods
Patients and controls
All individuals who participated in this study gave informed 
written consent. The study was approved by the Egyptian Bioethics 
Review Committee for Bioethics (BERD) VACSERA. Three hundred 
and ninety six unrelated patients with T1D from different governorates 
of Egypt were recruited consecutively. The diagnosis of T1D was 
based on ketoacidosis or ketosis with severe symptoms of acute onset 
at presentation and continuous dependence on insulin. Moreover, 
patients included in the study had a Glycated Hemoglobin (HbA1c) 
≥ 8.5 % [32,33].
All patients were non-obese and ≤ 14 yr of age at enrolment. 
Patients were separated into two groups for statistical analysis: younger 
than 6 yr of age (0-5 age group) and 6to 14 yr of age (6-14 age groups).
Healthy individuals older than 24 years of age - as recommended by 
the DiaMond protocol [34], with normal blood glucose (n=396) were 
selected randomly from the Egyptian population to serve as controls. 
This age restriction is placed on the controls to exclude subjects from 
the high-risk period of 0-14 yr of age, during which T1D is most likely 
to develop [18]. None of the controls had a family history of T1D. 
A standardized medical history questionnaire was completed by all 
patients and controls (Table 1). 
The diagnosis of T1D was confirmed by elevated anti-glutamic acid 
decarboxylase (GAD) antibodies and low C-peptide levels. In controls, 
anti-GAD antibodies were absent and C-peptide levels were within 
the reference range (0.4-2.2 ng/ml). Individuals who were suspected 
to have Maturity-Onset Diabetes of the Young (MODY) or Wolfram 
syndrome were excluded from the study. 
SNP genotyping
Blood (1 ml) was collected in EDTA-tubes, and the DNA was 
extracted by a salting out method [35]. The DNA was dissolved in 50 
μl Tris-EDTA (20 mM Tris, 2 mM EDTA, pH 7.5) buffer and stored at 
-20°C until use. 
Genomic DNA was amplified using PCR with different primers 
(forward and reverse) as shown in Table 2. Reaction volume was 50 µl: 
4 µl DNA at 100 ng/µl, 25 µl DreamTaq Green master mix (Fermentas, 
Lu), 3 μl of each primer (30 pmol/μl), and 15 μl H2O. Reaction 
conditions were carried out using a model PTC100 thermal cycler 
(M&J research, Watertown, MA, USA)
Following a PCR reaction carried out at 94°C for 5 min followed 
by 35 cycles of 94°C for 30 s. Finally two heating cycles were applied at 
ca. 50°C for 30 or 45 seconds and then 72°C for 30 sec (Table 3). Next, 
10 μl PCR product from each sample was resolved in 2% agarose gel to 
check the PCR products at the given bp fragment (Table 3). Restriction 
fragment length polymorphism (RFLP) analysis was done using the 
restriction enzymes given (Table 3) in 20 μl total volume by mixing: 10 
μl of PCR product + 1.0 μl restriction enzyme + 2.0 μl 10 X restriction 
enzyme’s buffer + 7 μl nuclease-free water. The mixture was incubated 
at the given temperatures (Table 3) for 1 hour. DNA fragments were 
resolved in 3.0% agarose gel visualized by Ethidium Bromide (EtBr) 
staining. The digested alleles yielded the fragments listed in Table 3.
Statistical analysis
Genotype and allele distribution differences between patients and 
controls were tested by the chi-squared test with Yates’ continuity 
correction. Statistical significance was defined as p< 0.05, when 
the calculated χ2>3.841 for 1 degree of freedom, and χ2>5.991 for 2 
degrees of freedom. Hardy-Weinberg equilibrium (HWE) was tested 
by comparing the expected and observed genotypes in 2 × 3 χ2 tables. 
None of the SNPs in patient or control groups deviated from the HWE. 
Power calculation was used the Genetic Power Calculator (http://pngu.
mgh.harvard.edu/~purcell/gpc/) [36]. Our sample had sufficient power 
(80%) to detect significant association of the studied SNPs for Odds 
ratios (OR) ranging between 1.6 and 1.05 for minor allele frequencies of 
0.07 till 0.48, respectively, assuming a co-dominant model of inheritance 
as has been suggested for CTLA-4. OR calculation, haplotypes and 
conditional analysis were calculated using the statistical program 
Unphased (https://sites.google.com/site/fdudbridge/software/) [37], 
which uses a logistic regression model to estimate effect sizes that are 
expressed as Ors [37]. The method is equivalent to calculating ORs and 
corresponding confidence intervals from 2×2 tables using the Woolf-
Haldane’s method [38]. Adjustments to the level of significance were 
made for multiple analyses by Bonferroni correction of 7 independent 
tests [39].
Results
In the present study, we analyzed seven SNPs spanning the entire 
DNA sequence of the CTLA-4 gene for association with T1D using a 
case/control study of an Egyptian population. All controls were negative 
for anti-GAD antibodies and were 25 yr of age or older. Furthermore, 
no control had a family history of T1D (Table 1). 
Genotype and allele distributions of the seven SNPs were tested 
for association with disease status (Tables 4 and 5). We observed 
significant association after correction for multiple testing for SNPs 
-1722, -1661, +49 A/G, -819, and CT60. The +49 A/G SNP had the 
strongest influence on disease state. Therefore, we proceeded to test all 
SNPs for independent association conditional on +49 A/G, and vice 
versa, +49 A/G conditional on all other SNPs (Table 6). This analysis 
demonstrated a +49 A/G independent association of SNPs -1661 
and -318 with T1D. Furthermore, evidence of +49 A/G independent 
associations were found for all other investigated SNPs except SNP 
-318.
SNP haplotype analysis
The observation that the association of +49 A/G had a stronger 
Patients All patients1-14 years old
Controls
>24 years old
Number of Patients 396 396






Weight (kg) 39.0 ± 9.67 75.4 ± 11.22
Sex, N (%) Female    198 (50)
Male       198 (50)
Female    198 (50)
Male       198 (50)
Glycated Hemoglobin (HbA1c) 
(Mean ± SD) 9.7 ± 1.45 5.6 ± 0.25
Table 1:  Demographics of the Study for Egyptian Population.
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Table 2: The primers used in PCR-RFLP technique for genotyping the SNPs of CTLA-4 in this study.
No SNP Name Forward primer Reverse Primer Alleles registered in NCBI
1 -1722C>T 5’CAAGCTTTGTCCTGTGACCA3’ 5’AAGCGCCAACAAGCATAAC3’ FJ013949FJ013950
2 -1661A>G 5’GCCACTGCTGTGTGTTCCT3’ 5’ATGTGCCTGTTGGTGTGAT3’ FJ013951FJ013952
3 -651C>T 5’TCCTTCTGCAAAACCAGAGGCAGCT3’ 5’AGTACAAGGGTCCTCCTAAATCCCA3’ GQ370246GQ370247
4 -318C/T 5’-AAGGATGCCCAGAAGATTGA3’ 5’AGCCGTGGGTTTAGCTGTTA3’ Q390244Q390245
5 +49A>G 5'-AAGGCTCAGCTGAACCTGGT-3' 5'CTGCTGAAACAAATGAAACCC3' DQ534199DQ534200
6 -819C>T 5’GGAGAGGGGCCTGGTTAGTTACA3’ 5’AGAGAGGCAGCGGTG GTGTCA3’ EU103999EU104000
7 CT60 (+6230G>A) 5’-CACCACTATTTGGGATATACC-3’ 5’AGGTCTATATTTCAGGAAGGC3’ GQ370006GQ370007
Abbreviations: NEB: New England Biolabs, UK; FL: Thermo Fisher Scientific, Inc (Fermentas), USA
Table 3:  Details of SNP genotyping.
-1722C>T -1661A>G -651C>T -318C>T +49 A>G -819C>T +6230G>A (CT60)
Temp 1 (°C) 50.5 53 57.5 58 55 62 59
Duration 1 (s) 45 30 30 30 30 40 30
Temp 2 (°C) 72 72 72 72 72 72 72
Duration 2 (s) 40 30 30 30 30 30 30
bp fragment 398 214 330 212 152 180 216
Restriction enzyme APek1 DraI Aci1 Tru1 Ecor911 CviKl-I NcoI
Source NEB FL NEB FL FL NEB FL
Incubation temp (°C) 37 65 37 65 37 37 65
Digested allele CC AA CC TT AA CC AA
Yielded fragments (bp) 266, 132 162 300 93, 119 131 69, 111 162
Digested allele TC AG CT CT AG CT AG
Yielded fragments (bp) 132, 266, 398 52, 162, 214 300, 330 93, 119, 212 131, 152 69, 111, 180 54, 162, 216
Digested allele TT GG TT CC GG TT GG
Yielded fragments (bp) 398 214 330 212 152 180 216
The table shows counts and percentages between brackets of the alleles of seven CTLA-4 SNPs studied. P-value (Pc) is corrected for multiple testing of seven SNPs. Odds 
Ratio (OR) and corresponding 95% confidence intervals are given for the minor allele
Table 4: Allelic association.
SNP (major/minor allele) Cases (%) Controls (%) Pc-value OR 95%CI
-1722(T>C)
(rs733618) 669 (84) 123 (16) 710 (90) 82 (10) 0.0294* 1.6 1.2-2.1
-1661 (A>G)
(rs4553808) 503 (64) 289 (36) 574 (72) 218 (28) 0.0182* 1.5 1.2-1.9
-651 (C>T)
(rs11571318) 714 (90) 78 (10) 736 (93) 56 (7) 0.658 1.4 1.0-2.1
-318 (C>T)
(rs5742909) 717 (91) 75 (9) 743 (94) 49 (6) 0.21 1.6 1.1-2.3
+49 (A>G)
(rs231775) 498 (63) 294 (37) 576 (73) 216 (27) 3.724E-04* 1.6 1.3-1.9
-819 (C>T)




347 (44) 445 (56) 409 (52) 383 (48) 0.0252* 1.4 1.1-1.7
influence on T1D outcome than CT60 may indicate different CTLA-
4 haplotypes in the Egyptian population. Therefore, the pattern of 
LD and CTLA-4 haplotypes in the Egyptian sample was calculated. 
In order to test LD between SNPs typed, the D’ values among seven 
SNPs were calculated using the estimated haplotype frequencies. 
All SNP combinations had a high absolute value of D’ except the 
combination of -651 with-319 SNPs. This observation may explain the 
lower association of these two SNPs with T1D. To further investigate 
this, all possible CTLA-4 haplotypes of all seven SNPs were calculated 
(Table 7). This analysis showed thirty three different haplotypes in 396 
Egyptian patients. The TACCACG haplotype (where the nucleotide is 
indicated for each of the seven SNPs, as shown in Table 7) was the 
most frequent in the Egyptian population (22.9% vs. 30.8% in cases 
and controls respectively). This haplotype was treated as the ‘wild 
type’ or reference haplotype. Odds Ratio’s of all other haplotypes were 
consequently calculated against this reference. As expected from the 
single SNP analysis, most haplotypes occurring more frequently in 
cases as compared to controls carried the susceptible G-allele at +49 
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A/G. Interestingly, the most frequent haplotype carrying a G-allele 
at +49 A/G (haplotype TACCGCA) did not confer risk. Significantly 
increased risk relative to the wild type haplotype was found for six 
haplotypes of which two were carrying the A-allele at +49 A/G.
These analyses demonstrated that the combination of these SNPs 
tag the undetected causal variant in a more efficient way than the single 
SNPs, confirming previous fine mapping studies. 
Discussion
Genetic mapping of causal variants of susceptibility genes for 
complex diseases such as T1D remains complicated. Several aspects may 
be responsible for this complexity. First, each gene variant accounts for 
only a small proportion of susceptibility, necessitating large samples 
to acquire sufficient power for dissection of the association signal. 
Furthermore, the association signal may be caused by multiple causal 
variants causing synthetic association [37]. Furthermore, conflicting 
The table shows counts and percentages between brackets of the genotypes of seven CTLA-4 SNPs studied.
P-values are corrected for multiple testing of seven SNPs
Table 5: Genotype association.
SNP (genotype) Cases (%) Controls (%) P-value
-1722 (TT/TC/CC) 282 (71) 105 (27) 9 (0.03) 318 (0.80) 74 (19) 4 (1) 0.084
-1661 (AA/AG/GG) 159 (40) 185 (47) 52 (13) 208 (53) 158 (40) 30 (7) 0.0098*
-651 (CC/CT/TT) 318 (80) 78 (20) 0 (0) 343 (86) 50 (13) 3 (1) 0.112
-318 (CC/CT/TT) 325 (82) 67 (17) 4 (1) 347 (88) 49 (12) 0 (0) 0.84
49 (AA/AG/GG) 157 (40) 184 (46) 55 (0.14) 211 (53) 154 (39) 31 (8) 0.0028*
-819 (CC/CT/TT) 181 (46) 178 (45) 37 (9) 214 (54) 164 (41) 18 (5) 0.098
+6230 (AA/AG/GG) 76 (19) 195 (49) 125 (32) 107 (27) 195 (49) 94 (24) 0.112
The table shows Bonferroni corrected p-values for conditional testing of each SNP conditional on +49 A/G SNP (first column), and of +49 A/G SNP conditional on each 
SNP (second column)
Table 6: Results of test of conditional association.







The table shows counts and percentages of estimated haplotypes. P-values (Pc) are corrected for 23 haplotype comparisons. Odds Ratio (OR) and corresponding 95% 
confidence intervals are given, whereas Global D’ for cases and controls are 0.7182 and 0.7922, respectively
Table 7: Haplotypes of seven CTLA-4SNPs in the Egyptian T1D and control samples.
Haplotype Case Control Ca-Freq Co-Freq Ca-D' Ca-r2 Co-D' Co-r2 Odds-R 95%Lo 95%Hi Pc
TACCACG 181 244 22.9% 30.8% 0.8825 0.03714 0.9021 0.04237 1 1 1
TGCCACA 64 78 8% 9.8% -0.009883 7.75e-5 -0.03606 0.001167 1.11 0.76 1.62
TACCGCA 59 108 7.4% 13.6% 1 0.01344 1 0.01829 0.74 0.51 1.07
TACCATA 52 80 6.5% 10.1% 1 0.01227 1 0.01291 0.88 0.59 1.31
CGCCGCA 41 34 5.2% 4.3% 1 0.4007 1 0.384 1.63 1.00 2.67
TGCCATG 41 33 5.2% 4.2% -0.02038 0.000205 0.5242 0.001439 1.68 1.03 2.76
TACCGCG 31 6 3.9% 0.76% 1       0.01066 1       0.000914 6.28 2.62 15.06 0.00003
TACCACA 22 28 2.8% 3.5% -0.002983 2.422e-6 0.6362 0.001765 1.09 0.61 1.95
TACCATG 21 5 2.7% 0.6% 1 0.004763 1 0.0007987 4.65 1.84 11.76 0.004
TGCCGCG 19 17 2.4% 2.1% -0.1551 0.005829 0.179 8.718e-5 1.50 0.76 2.95
TACTGTG 19 1 2.4% 0.13% 1 0.004202 1 9.68e-5 15.76 2.44 101.70 0.00007
TATCACA 16 29 2% 3.7% 1 0.003412 1 0.00432 0.76 0.40 1.43
TACTGCA 14 0 1.8% 0% 1       0.003412 1 0.00432 16.04 1.61 159.83 0.0007
CGCCGTG 13 20 1.6% 2.5% 1 0.005063 1 0.004677 0.87 0.43 1.79
TACCGTA 12 2 1.5% 0.25% 1 0.1223 0.7455 0.1629 6.99 1.56 31.37 0.02
TATCATG 11 15 1.4% 1.9% 1 0.002475 1 0.002209 1.03 0.47 2.26
TATCATA 10 2 1.3% 0.25% 1 0.002279 1 0.0002206 5.82 1.29 26.19
CGCCACA 10 12 1.3% 1.5% 0.009883 7.75e-5 0.03606 0.001167 1.10 0.47 2.58
TACTACA 10 31 1.3% 3.9% 1 0.0025315 1 0.002338 0.46 0.22 0.96
TGCCGTA 9 5 1.1% 0.6% 1 0.001878 1 0.000662 2.32 0.77 7.04
CGTCGTG 7 7 0.9% 0.9% 0.6348 0.0373 0.7977 0.05621 1.36 0.47 3.92
TACCGTG 7 5 0.9% 0.5% 1 0.00137 1 0.0007303 1.73 0.56 5.34
TACTATG 0 13 0% 1.6% 1 5.987e-13 1 0.001956 0.10 0.01 1.61 0.05
Other 123 17 15.5% 2.1% ------- -------- -------- ------ ----- ------ ------ --------
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results from different populations may be caused by certain mutations 
that may not exist in all racial/ethnic groups or geographical populations. 
Therefore, screening of hitherto uninvestigated populations may help 
elucidating genetic complexities [31].
We have previously investigated  the prevalence of C-819T and 
A+49G SNPs of the CTLA-4 gene in male and female Egyptian children 
[40]. In the present paper we analyzed SNP associations and performed 
haplotyped analysis of 7 SNPs of the CTLA-4 Ig gene in T1D. This study 
confirmed association of five SNPs of the CTLA-4 gene with T1D in 
the Egyptian population and demonstrated that distinct susceptibility 
haplotypes exist in this patient cohort of Egyptian origin. The current 
analysis confirmed the association of CTLA-4 polymorphism with 
T1D in the Egyptian population. In contrast to previous fine mapping 
in European samples where the CT60 SNP had the strongest influence 
on disease state [8], in the present study, the strongest association 
mapped to the +49 A/G SNP located in the first exon and not to the 
more 3-prime region of the CTLA-4 gene. The +49 A/G SNP has been 
extensively studied in several ethnic populations of mostly European 
ancestry with conflicting results [11,41,42]. However, our haplotype 
analysis demonstrated that haplotypes not carrying the susceptible 
G-allele at +49 A/G were also detected in two susceptible haplotypes. 
This observation suggested that the +49 A/G were not the only variant 
influencing T1D. Conditional analysis further demonstrated that it is 
unlikely that either +49 or any of the other associated SNPs alone can 
be responsible for T1D risk. Rather a network of SNPs seems to have a 
prognostic relevance.
The pattern of LD and CTLA-4 haplotypes in the Egyptian sample 
was compared to previously published data of another North African 
population in Morocco. In comparison with the haplotypes found in 
Morocco, several differences illustrated the genetic diversity in this 
region. Bouqbis et al. published frequencies for four SNP haplotypes 
(SNPs -1722,-1661,-319 and +49) and reported that the TACA 
haplotype was the most frequent at 54.4% in the South Moroccan 
population [19]; similarly to the Egyptian population (54%) in our 
study. Moreover, Bouqbis et al. reported that haplotype TGCA had 
the strongest association with T1D [19]. In our sample, this was clearly 
different regarding the -1661 and +49 SNPs: the TACG haplotype 
had the strongest association with T1D in the investigated Egyptian 
population. However, given the limited sample size of our study and 
that of Bouqbis et al. these differences could represent stochastic 
variation due to sampling error [19]. Our results do not confirm the 
absence of association of the +49 A/G variant in Egyptian population 
as in the West African and the Moroccan populations [18]. Therefore, 
the finding reported by Bouqbis et al. may be unique for the population 
studied, and again points to the fact that it is unlikely that the+49 A/G 
SNP alone is a causal variant [19]. The samples studied by Bouqbis 
et al. were derived from Agadir town in south Morocco, which is 
geographically near to West Africa, but far from Egypt [19]. 
Furthermore, the +49 A/G allele has been found to be associated 
with T1D in Mediterranean populations, which are related to the 
North African populations generally and to the Egyptian specifically. 
Therefore, further studies comparing North and West African 
populations may clarify differences in the pattern of association of the 
CTLA-4 gene region and further fine map the disease variant in CTLA-
4.
In summary, a strong association of the +49 A/G SNP in the 
CTLA-4 gene with T1D was found in a sample of Egyptian origin. 
The pattern of association was distinct from that observed previously 
in other populations, providing further evidence to the clarification of 
demographic and disease associations of different CTLA-4 SNPs. 
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